Data / Form D filings / MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc.: Form D filing
MAIA Biotechnology, Inc., a biotechnology company in Chicago, IL, filed a Form D with the SEC in 2026. The latest, on January 5, 2026, reports $1.5 million sold of a $2 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 444 WEST LAKE STREET SUITE 1700, Chicago, IL, 60606
- Phone
- (312) 416-8592
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1878313
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 5 | New notice | $2,000,000 | $1,509,789 | $490,211 | 17 | Dec 22 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Vlad Vitoc | Executive Officer, Director | Chief Executive Officer, President and Chairman of the Board of Directors |
| Jeffrey Himmelreich | Executive Officer, Director | Head of Finance |
| Sergei Gryaznov | Executive Officer | Chief Scientific Officer |
| Jean-Manasse Theagene | Director | |
| Steven Chaouki | Director | |
| Stan Smith | Director | |
| Ramiro Guerrero | Director | |
| Louie Ngar Yee | Director | |
| Cristian Luput | Director |
Every Form D from the week of Jan 5 · All recent filings in Illinois · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MAIA Biotechnology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.